Interviews

Experts discuss practice-changing issues

Long-Term Impact of the ASH Scholar Award Program

Saturday, August 20th, 2016
The American Society of Hematology’s (ASH) longest-running award program, the ASH Scholar Award, celebrates more than 30 years of financially supporting fellows and junior...

The Road to the New Sickle Cell Disease Guidelines: Interview with Co-Chair George R....

Sunday, January 10th, 2016
On September 9, 2014, the National Heart, Lung, and Blood Institute (NHLBI) released an evidence-based expert panel report on the management of sickle cell...

Bridging the Gap: How ASH Bridge Grant Recipients are Advancing Research

Tuesday, December 1st, 2015
Biomedical researchers are operating in a tepid – lukewarm, at best – funding environment. The National Institutes of Health (NIH), a major source of...

Improving Care Through Technology, Policy, and Philanthropy

Wednesday, November 18th, 2015
David Blumenthal, MD, heard the call to public service at an early age. His professional career has ranged from primary-care clinical practice to government service...

If You Build It, They Will Come: Robert Negrin Shares His Vision for Blood...

Monday, November 9th, 2015
When Robert Negrin, MD, was growing up in Silver Spring, Maryland, if someone had told his parents that their son would one day become...

Revisiting Maintenance of Certification: Updates from ASH and ABIM Interview with Marc S....

Wednesday, April 8th, 2015
In 2015, the American Board of Internal Medicine (ABIM) issued a statement in response to numerous criticisms from diplomates and specialty societies, including the...

Grassroots Lobbying Efforts Lead to a Win for SCD Patients in Tennessee: An Interview...

Sunday, February 15th, 2015
Sickle cell disease (SCD) is the most common, inherited red blood cell disorder in the United States – affecting 70,000 to 100,000 Americans. Although...
Advertisement

Current Issue

March 2017, Volume 3, Issue 4

This issue takes a look at diversity in the medical education system, provides a hematology drug pipeline update, and more.